Alnylam Pharmaceuticals
ALNY
#567
Rank
S$48.87 B
Marketcap
$379.14
Share price
-2.20%
Change (1 day)
69.04%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company